$8.39
-0.83-9%
Last update: Nov 12, 5:06 PM
Candel Therapeutics Inc (CADL) Stock Price, Quote, News & History
CADLNASDAQ
Candel Therapeutics presented positive phase 3 prostate cancer data showing improved disease-free survival, while analysts maintained bullish expectations on...
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Other companies in Candel Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Candel Therapeutics has a consensus price target of $20.55.
The stock price for Candel Therapeutics (NASDAQ: CADL) is $4.85 last updated November 12, 2026 at 5:06 PM EST.
There are no upcoming dividends for Candel Therapeutics.
Candel Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Candel Therapeutics.
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced...
